SCHEMBL22764802

SCHEMBL22764802

CCCCCC1C(O)CCC1CCCO

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 6/20 0.39
GLB1 P16278 3/20 0.38
GBA2 Q9HCG7 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
GBA1 P04062 2/20 0.37
ALDH1A1 P00352 3/20 0.37
LMNA P02545 2/20 0.37
HSD17B10 Q99714 2/20 0.37
TSHR P16473 2/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
ALOX5 P09917 1/20 0.35
TP53 P04637 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
ALOX15 P16050 1/20 0.34
NFKB1 P19838 1/20 0.34
MAPK1 P28482 1/20 0.34
THPO P40225 1/20 0.34
TDP1 Q9NUW8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9623388 0.95 LMNA (0.45) CNR2GLB1GBA2SMN1; SMN2GBA1
SCHEMBL7115175 0.91 GLB1 (0.46) GLB1GBA2SMN1; SMN2GBA1ALDH1A1
SCHEMBL670536 0.91 GLB1 (0.46) GLB1GBA2SMN1; SMN2GBA1ALDH1A1
SCHEMBL18853802 0.91 GLB1 (0.46) GLB1GBA2SMN1; SMN2GBA1ALDH1A1
SCHEMBL20829025 0.89 GBA1 (0.47) GLB1GBA2GBA1ALDH1A1LMNA
SCHEMBL19602220 0.89 SMN1; SMN2 (0.44) CNR2GLB1GBA2SMN1; SMN2ALDH1A1
SCHEMBL8749490 0.85 GLB1 (0.44) GLB1GBA2GBA1
SCHEMBL19754907 0.83 ALDH1A1 (0.52) CNR2GLB1GBA2SMN1; SMN2GBA1
SCHEMBL13253549 0.83 ALDH1A1 (0.52) CNR2GLB1GBA2SMN1; SMN2GBA1
SCHEMBL12670425 0.83 ALDH1A1 (0.52) CNR2GLB1GBA2SMN1; SMN2GBA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200383325-A1 SYNERGISTIC BITING ARTHROPOD REPELLENT FORMULATIONS BEDOUKIAN RESEARCH, INC. (US) 2020-12-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200383325-A1 SYNERGISTIC BITING ARTHROPOD REPELLENT FORMULATIONS ACMSD, NOTUM, PRMT5 CNR2 1563/4885GLB1 4330/4885GBA2 3726/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.